For people who are seriously ill and not eligible for a clinical trial, the main pathway to access investigational medicines, Johnson & Johnson Innovative Medicine (J&J IM) accepts requests for our investigational medicines from their treating physicians. Below are the number of patients to whom J&J IM has provided pre-approval access (PAA) annually since 2015:
Year | Number or requests approved |
2015 | 175 |
2016 | 1,901 |
2017 | 1,111 |
2018 | 726 |
2019 | 469 |
2020 | 552 |
2021 | 991 |
2022 | 1,539 |
2023 | 1,781 |
2024 | 637 |
Total | 9,882 |
For more information about PAA at J&J Innovative Medicine, please click here.